GRM7 polymorphisms are not associated with ischemic stroke in Iranian population

Area of Science:

• Neuroscience
• Genetics
• Epidemiology

Background:

• Ischemic stroke is a leading cause of adult disability and mortality.
• Candidate gene association studies are crucial for understanding stroke risk factors.
• The role of Glutamate Metabotropic Receptor 7 (GRM7) in ischemic stroke remains unclear.

Purpose of the Study:

• To identify potential associations between GRM7 gene variants and ischemic stroke risk.
• To investigate the genetic contribution of GRM7 to ischemic stroke in the Iranian population.

Main Methods:

• Genotyping of two intronic single nucleotide polymorphisms (SNPs) in the GRM7 gene (rs6782011 and rs779867).
• Case-control study design involving 318 ischemic stroke cases and 300 healthy controls from the Iranian population.
• Analysis of allele, genotype, and haplotype frequencies, with correction for multiple comparisons.

Main Results:

• No statistically significant differences were observed in allele frequencies between ischemic stroke cases and controls.
• Genotype and haplotype frequencies of the studied GRM7 SNPs did not differ significantly between the case and control groups.
• Statistical analysis, including correction for multiple comparisons, confirmed the lack of association.

Conclusions:

• The investigated GRM7 gene variants (rs6782011 and rs779867) are not associated with ischemic stroke risk in the Iranian population.
• These findings suggest that GRM7 may not play a significant role in the genetic predisposition to ischemic stroke in this demographic.
• Further research with larger cohorts and different genetic variants may be warranted to fully elucidate GRM7's role in stroke etiology.